Anebulo Pharmaceuticals's total assets for Q3 2025 were $14.01M, a decrease of -11.57% from the previous quarter. ANEB total liabilities were $546.03K for the fiscal quarter, a -37.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.